bioRxiv · 10.1101/2024.10.29.620930
Telmisartan impedes JEV infection predominately via AT1/PPARγ axis
Abstract
Japanese encephalitis, caused by Japanese encephalitis virus (JEV) is a vector born disease for which no specific therapeutics are available yet. Binding of angiotensin II (Ang II) to angiotensin II type 1 (AT1) receptor induces release of inflammatory cytokines associated with viral encephalitis. Accordingly, Ang II receptor blockers (ARBs) have been proposed to manage encephalitis. Since Telmisartan (TM, antagonist of AT1 and agonist of PPAR{gamma}) has relatively better brain access than other ARBs, this investigation aims to evaluate its anti-JEV efficacy in vitro and in vivo. TM reduced JEV titer, RNA and protein (NS3) significantly in the BHK-21 cells with IC50 of 24.68M and CC50 of >350 M (Selectivity Index >14.18) indicating its potential of repurposing against JEV. The anti-JEV efficacy of TM was further observed in macrophages (RAW264.7) and neuronal (SH-SY5Y) cells. Interestingly, the viral load was reduced significantly in pre, co and post-treatment conditions of TM, however most efficiently (80%) in post treatment. In presence of GW (PPAR{gamma} antagonist) and AG (AT1 agonist), viral infection was increased remarkably while AT1 was upregulated and PPAR{gamma} was downregulated. Whereas, TM treatment reversed the levels of AT1 and PPAR{gamma} during infection. Further, reduction of inflammatory markers like p-IRF-3, COX-2 and p-NF-{kappa}B was observed after TM treatment in RAW264.7 cells suggesting its immunomodulation through the AT1/PPAR{gamma} axis. Finally, the anti-JEV potential of TM was validated in mice model through the reduction of disease score, viral protein and histological changes. Thus, the preclinical efficacy of TM suggests its suitability for repurposing against JEV.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Datey, A., Chatterjee, S., Ghosh, S., Kumar, P. S., De, S., Ghorai, U., Subudhi, B. B., Chattopadhyay, S.. 2024-10-29. Telmisartan impedes JEV infection predominately via AT1/PPARγ axis. https://doi.org/10.1101/2024.10.29.620930
Cite the original work for its findings. Save a collection to share your selection of sources.